Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 1
2018 1
2019 2
2020 4
2021 4
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
STING-induced regulatory B cells compromise NK function in cancer immunity.
Li S, Mirlekar B, Johnson BM, Brickey WJ, Wrobel JA, Yang N, Song D, Entwistle S, Tan X, Deng M, Cui Y, Li W, Vincent BG, Gale M Jr, Pylayeva-Gupta Y, Ting JP. Li S, et al. Among authors: mirlekar b. Nature. 2022 Oct;610(7931):373-380. doi: 10.1038/s41586-022-05254-3. Epub 2022 Oct 5. Nature. 2022. PMID: 36198789 Free PMC article.
Impact of IL-23 in prostate cancer.
Mirlekar B. Mirlekar B. Asian J Androl. 2022 Mar-Apr;24(2):223-224. doi: 10.4103/aja2021100. Asian J Androl. 2022. PMID: 34850747 Free PMC article. No abstract available.
IL-12 Family Cytokines in Cancer and Immunotherapy.
Mirlekar B, Pylayeva-Gupta Y. Mirlekar B, et al. Cancers (Basel). 2021 Jan 6;13(2):167. doi: 10.3390/cancers13020167. Cancers (Basel). 2021. PMID: 33418929 Free PMC article. Review.
Regulatory B cells in cancer.
Michaud D, Steward CR, Mirlekar B, Pylayeva-Gupta Y. Michaud D, et al. Among authors: mirlekar b. Immunol Rev. 2021 Jan;299(1):74-92. doi: 10.1111/imr.12939. Epub 2020 Dec 23. Immunol Rev. 2021. PMID: 33368346 Free PMC article. Review.
B cell-Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer.
Mirlekar B, Michaud D, Lee SJ, Kren NP, Harris C, Greene K, Goldman EC, Gupta GP, Fields RC, Hawkins WG, DeNardo DG, Rashid NU, Yeh JJ, McRee AJ, Vincent BG, Vignali DAA, Pylayeva-Gupta Y. Mirlekar B, et al. Cancer Immunol Res. 2020 Mar;8(3):292-308. doi: 10.1158/2326-6066.CIR-19-0349. Epub 2020 Feb 5. Cancer Immunol Res. 2020. PMID: 32024640 Free PMC article.
17 results